SEGMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

SCHEDULE OF FINANCIAL INFORMATION OF REPORTABLE SEGMENT

Summarized financial information concerning the Company’s reportable segments is shown as below:

By Categories

	For the year ended December 31, 2023
	Range Reclaim		Range Water			Range Security		Range Land			Drug Development			Corporate			Total
Sales	$	18,662,111	$	-		$	684,195	$	-		$	-		$	-		$	19,346,306
Cost of services		12,808,990		-			302,507		-			-			-			13,111,497
Gross profit		5,853,121		-			381,688		-			-			-			6,234,809
Operating income (loss)		3,784,444		(69,840	)		269,772		(13,134	)		(458,889	)		(1,757,989	)		1,754,364
Net income (loss)		3,407,546		(69,840	)		269,548		(13,134	)		(458,889	)		(4,176	)		3,131,055
Total assets		21,079,343		13,859			155,783		1,009,794			8,753			1,520,612			23,788,144
Depreciation		1,769,766		1,706			10,101		-			-			-			1,781,573
Interest expense		376,898		-			224		-			-			128,795			505,917
Capital expenditures for long-lived assets	$	1,050,640	$	15,350		$	52,674	$	1,008,897		$	-		$	-		$	2,127,561

	For the year ended December 31, 2022
	Range Reclaim		Drug Development			Corporate			Total
Revenue	$	4,832,278	$	-		$	-		$	4,832,278
Cost of services		3,439,026		-			-			3,439,026
Gross profit		1,393,252		-			-			1,393,252
Operating income (loss)		761,432		(470,803	)		(1,391,062	)		(1,100,433	)
Net income (loss)		816,469		(470,803	)		(1,417,842	)		(1,072,176	)
Total assets		6,056,568		-			2,173,897			8,230,465
Depreciation		395,543		-			-			395,543
Interest expense		54,402		-			26,776			81,178
Capital expenditures for long-lived assets	$	5,813,057	$	-		$	-		$	5,813,057